Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02580448
Title A Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of VT-464 in Patients With Advanced Breast Cancer
Recruitment Completed
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Innocrin Pharmaceutical
Indications

triple-receptor negative breast cancer

estrogen-receptor positive breast cancer

Therapies

VT-464

Age Groups: adult
Covered Countries USA


No variant requirements are available.